LUNGevity Foundation

LUNGevity Foundation expresses deep concern regarding the recent budget and staffing cuts at agencies within the Department of Health and Human Services (HHS), which threaten to have a devastating impact on lung cancer research and the progress that has been made in improving patient outcomes. Lung cancer remains the leading cause of cancer-related deaths in the United States, and despite significant advances in research and treatment, there is still much more to be done. The proposed cuts to funding and staffing at the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC) will have a profound impact on cancer research, timely review of new diagnostics and therapies, and responding to current and future public health threats. The elimination of research positions at the NIH comes at a time when we should instead be increasing investment in the pipeline of young scientists to spur new discoveries in lung cancer and hundreds of other diseases. These cuts will have a chilling effect on our ability to recruit and retain the best researchers to help solve our most challenging health issues. These cuts also severely weaken, and in some cases eliminate, critical lung health initiatives, including the CDC’s National Asthma Control Program, the CDC’s Office on Smoking and Health, the CDC’s Global Tuberculosis Program, and parts of the FDA’s Center for Tobacco Products. Reducing staffing and funding for these programs threatens efforts to prevent and manage respiratory diseases, curb tobacco-related illnesses, and advance public health interventions that are essential for reducing lung cancer risk. While private organizations, such as LUNGevity Foundation, play a vital role in funding lung cancer research, supporting patients, and advancing education, government agencies have been key drivers of this progress, and foundations and industry cannot fill the gap created by a lower investment in basic science. LUNGevity urges the administration to reconsider these cuts and prioritize funding for research and public health programs that are essential for lung cancer research. We stand with the researchers, healthcare professionals, and advocates who are committed to advancing science and care for all those affected by lung cancer, and we call on policymakers to protect the investments that are saving lives today and into the future. Learn more: https://lnkd.in/eyiGVCnd

#HealthCareProviders: Appetite loss and nausea are common side effects of cancer treatment. To get enough calories and to reduce nausea try eating smaller portions more frequently. You can pack snacks to have nearby to still be able to eat while you are away from home. Preventing an empty stomach by eating more often can reduce or prevent nausea. Register for Ina® for more tips for managing side effects of cancer treatment. It is free and accessible 24/7. https://lnkd.in/evxPdP_e

Rosemary can’t wait for #HOPESummit25 taking place the first weekend in May in Bethesda, Maryland. Join her and meet your lung cancer community. Register for free now! LUNGevity.org/hopesummit

Happy National Doctors Day! Thank you to all who work tirelessly to help the lung cancer community live longer, fuller lives. You are appreciated! Want to learn more about the doctors who are part of a lung cancer patient's care team? Visit https://lnkd.in/e2JetYJs

Every day 643 people will be diagnosed with lung cancer. Share the facts and raise awareness that #AnyoneWithLungs can get lung cancer. Learn about risk factors, screening, and more by visiting lungevity.org

With only a month to go until the #bigsurmarathon, we are wishing Abigail and all of our #TeamLUNGevity athletes the best of luck in their final weeks of training. We thank them for raising lung cancer awareness and vital funds to improve the lives of people living with the disease. Are you ready to join the team? Visit TeamLUNGevity.org to learn more!

Do you want to know more about lung cancer surgery? Read our latest blog to learn about the types of lung cancer surgeries, who should have surgery, and additional treatment options. Read now: https://lnkd.in/eeXhkSaV

Colleagues traveling to the National Comprehensive Cancer Network® (NCCN®) 2025 Annual Conference tomorrow, LUNGevity Foundation invites you to visit us at Booth A-3 in the Patient Advocacy Pavilion. You can explore our comprehensive resources to support patients, caregivers, and healthcare professionals. Our offerings include: 🔹 A medically-vetted website with reliable lung cancer information 🔹 Patient Gateways tailored to specific lung cancer types 🔹 A HELPLine providing personalized support 🔹 Survivorship conferences fostering education and connection 🔹 Tools to help patients navigate clinical trials These programs are part of our commitment to achieving a world where no one dies of lung cancer. We look forward to connecting with you! #NCCN2025 #LungCancer #PatientAdvocacy #HOPESummit #CancerSupport

Happy Social Work Month! A big shoutout and thank you to all of the Social Workers in our community. You are vital to helping people live longer, fuller lives with lung cancer. Learn about the role a social worker can play in your lung cancer care by visiting https://lnkd.in/e4uaK2vQ

Are you interested in learning about new RET-targeted therapies? Join us for an engaging Facebook Live discussion on how these innovative treatments work and their potential in the treatment of RET-positive cancers. Emily Walthall and Hilary Hammell from the RETpositive community join Justin Drake, PhD, who will dive into the world of protein degraders – a groundbreaking new class of drugs that show promise in preclinical cancer models. Tune in at facebook.com/lungevity